More Articles

Patients and Medical

Patient engagement: Breaking through in digital

Andrew Stone, (Oct 14, 2020)

The pandemic is serving as an accelerated lesson in the possibilities of digital engagement. Now pharma must work out how to harness its full potential

Adapting to the multichannel imperative: A special report

Andrew Stone, (Oct 8, 2020)

Pharma’s gradual evolution into digital-first commercial has become urgent in the COVID-19 world. A comprehensive multi-channel approach including the use of digital tools to enhance customer engagement will transform pharma sales.

COVID-19: The tipping point for rapid tech adoption

Andrew Stone, (Oct 2, 2020)

A new pandemic-driven technological revolution is reshaping the entire healthcare system in 2020 and everyone’s sense of what is possible beyond it
Patients and Medical

Amplifying the patient voice in rare disease access

Elly Aylwin-Foster, (Oct 2, 2020)

Rare disease patients are organising like never before, turning up the publicity volume and becoming ever more active in driving cures in the lab and even the boardroom
Patients and Medical

From complexity to clarity in cell and gene therapy

Andrew Stone, (Sep 16, 2020)

Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about their exciting possibilities

Australia’s field force: evolving on fast forward

Lucy Fulford, (Sep 16, 2020)

Australian pharma’s field force roles are changing fast and the new digital-first environment is driving a need for new approaches and new skillsets
Patients and Medical

The future of Medical Affairs: A virtual Q&A with Charlotte Kremer

Andrew Stone, (Sep 10, 2020)

The Astellas head of medical affairs follows up with answers to questions during her virtual keynote earlier this year
Access and Evidence

Survey results: Accelerating digital transformation during COVID-19

Nicola Davies, (Sep 4, 2020)

View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations

Paying for cell and gene therapy - Is the future already here?

Ulrich Neumann, (Aug 25, 2020)

Multiple novel payment models for CGT are in development but an open and collaborative approach among all healthcare stakeholders is needed if the significant legal and practical barriers are to be overcome
Patients and Medical

The future of medical congresses

Katie Osborne, (Aug 18, 2020)

The mega congresses of the past look likely to make way for more virtual, focused and, probably, hybrid physical/digital events